NUP98 GENE REARRANGEMENT

Clinical trials for NUP98 GENE REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new NUP98 GENE REARRANGEMENT trials appear

Sign up with your email to follow new studies for NUP98 GENE REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for leukemia patients who have run out of options

Disease control Ongoing

This study is testing a new oral drug called BN104 for adults and adolescents with acute leukemia that has returned or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help control the cancer. The trial is specifically for patie…

Matched conditions: NUP98 GENE REARRANGEMENT

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NUP98 GENE REARRANGEMENT

Get alerted when new NUP98 GENE REARRANGEMENT trials appear

New hope for leukemia patients who have run out of options